- Home
- MOS vs QGEN Comparison
MOS vs QGEN Comparison
Compare MOS & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOS
- QGEN
- Stock Information
- Founded
- MOS 2004
- QGEN 1986
- Country
- MOS United States
- QGEN Netherlands
- Employees
- MOS N/A
- QGEN N/A
- Industry
- MOS Agricultural Chemicals
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MOS Industrials
- QGEN Health Care
- Exchange
- MOS Nasdaq
- QGEN Nasdaq
- Market Cap
- MOS 8.4B
- QGEN 9.9B
- IPO Year
- MOS 2004
- QGEN 1996
- Fundamental
- Price
- MOS $25.76
- QGEN $39.57
- Analyst Decision
- MOS Hold
- QGEN Buy
- Analyst Count
- MOS 11
- QGEN 8
- Target Price
- MOS $30.44
- QGEN $49.79
- AVG Volume (30 Days)
- MOS 4.5M
- QGEN 1.4M
- Earning Date
- MOS 02-27-2025
- QGEN 02-05-2025
- Dividend Yield
- MOS 3.42%
- QGEN 3.40%
- EPS Growth
- MOS N/A
- QGEN N/A
- EPS
- MOS 1.15
- QGEN 0.38
- Revenue
- MOS $11,456,400,000.00
- QGEN $1,978,214,000.00
- Revenue This Year
- MOS N/A
- QGEN $7.22
- Revenue Next Year
- MOS $4.32
- QGEN $6.74
- P/E Ratio
- MOS $22.37
- QGEN $101.34
- Revenue Growth
- MOS N/A
- QGEN 0.66
- 52 Week Low
- MOS $23.56
- QGEN $38.49
- 52 Week High
- MOS $33.44
- QGEN $47.93
- Technical
- Relative Strength Index (RSI)
- MOS 41.98
- QGEN 34.64
- Support Level
- MOS $26.26
- QGEN $38.49
- Resistance Level
- MOS $27.43
- QGEN $40.21
- Average True Range (ATR)
- MOS 0.98
- QGEN 0.74
- MACD
- MOS -0.19
- QGEN -0.28
- Stochastic Oscillator
- MOS 12.54
- QGEN 18.91
About MOS Mosaic Company (The)
Formed in 2004 by the combination of IMC Global and Cargill's fertilizer business, Mosaic is one of the largest phosphate and potash producers in the world. The company's assets include phosphate rock mines in Florida, Brazil, and Peru and potash mines in Saskatchewan, New Mexico, and Brazil. Mosaic also runs a large fertilizer distribution operation in Brazil through its Mosaic Fertilizantes business, which the company acquired from Vale in 2018.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).